RKT - Reckitt Benckiser Group plc
LSE
->
Consumer Defensive
->
Household & Personal Products
Slough,
United Kingdom
Type: Equity
RKT price evolution
RKT
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $1228.23 | $1309.49 | $861.41 | $1108.47 |
| Long term investments | ||||
| Property, plant & equipment | $526.01 | $547.94 | $556.88 | $598.55 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $25118.13 | $23648.71 | $22219.17 | $19231.74 |
| Current liabilities | ||||
| Accounts payable | $175.93 | $205.95 | $189.04 | $171.35 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $11400.8 | $9664.07 | $8465.41 | $5669.21 |
| Long term debt | $4068.07 | $4067.93 | $4066.14 | $4064.45 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $24465.74 | $22990.04 | $21567.78 | $18606.84 |
| Shareholders' equity | ||||
| Retained earnings | $278.95 | $300.96 | $300.49 | $284.3 |
| Other shareholder equity | $0.06 | $0.09 | $0.07 | $0.05 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2054.1 | |||
| Short term investments | ||||
| Net receivables | $87.36 | $80.72 | $114.69 | $324 |
| Inventory | ||||
| Total current assets | $1354.08 | $995.9 | $2414.87 | $24941.38 |
| Long term investments | ||||
| Property, plant & equipment | $598.55 | $640.38 | $682.27 | $211.16 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $12593.22 | |||
| Total investments | ||||
| Total assets | $19231.74 | $20082.21 | $32774.89 | $37534.6 |
| Current liabilities | ||||
| Accounts payable | $171.35 | $116.33 | $271.54 | $251.96 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $5669.21 | $6415.04 | $17332.29 | $876.14 |
| Long term debt | $4064.45 | $4049.47 | $4118.99 | $21420.88 |
| Total noncurrent liabilities | $28776.31 | |||
| Total debt | ||||
| Total liabilities | $18606.84 | $19505.51 | $32109.23 | $29652.45 |
| Shareholders' equity | ||||
| Retained earnings | $284.3 | $300.39 | $378 | $207.42 |
| Other shareholder equity | $0.05 | $0.07 | $0.08 | $7391.97 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $748.77 | $1382.02 | $1435.16 | $771.34 |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1057.73 | $1025.32 | $1011.07 | $861.86 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$15.89 | $14.12 | $7.66 | -$10.21 |
| Interest expense | -$140.44 | -$119.66 | -$89.81 | -$115.9 |
| Net income | ||||
| Net income | -$22.01 | $1.29 | $16.21 | -$10.63 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4005.86 | $6005 | $13176 | $15735.18 |
| Cost of revenue | ||||
| Gross Profit | $15735.18 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $3907.1 | $4744 | $5865 | $6203.52 |
| Operating income | $9531.66 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$12.82 | $42 | $113 | $132.38 |
| Interest expense | -$359.97 | -$320 | -$492 | $186.3 |
| Net income | ||||
| Net income | -$15.51 | $46 | $308 | $197.95 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$459.82 | -$226.03 | $35.46 | $861.15 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $5043.84 | $3560.98 | $2733.5 | -$623.56 |
| Effect of exchange rate | $0.16 | $0.52 | $0.31 | -$0.19 |
| Change in cash and equivalents | $111.77 | $200.43 | -$243.45 | $347.73 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Net income | $9399.28 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$1677.37 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $861.15 | $579 | -$665 | $517.2 |
| Financing activities | ||||
| Dividends paid | -$1375.18 | |||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$623.56 | -$12824 | -$6921 | $1757.66 |
| Effect of exchange rate | -$0.19 | -$1 | $0.89 | |
| Change in cash and equivalents | $347.73 | -$1423 | $158 | $598.38 |
News
Fundamentals
| Market cap | $9.59T |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.99B |
| Revenue | $4.34B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$15.14M |
| Revenue Q/Q | -71.94% |
| Revenue Y/Y | -73.85% |
| P/E ratio | -633.34K |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.21K |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.01 |
|---|---|
| ROA | -0.07% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.11 |
| Quick ratio | N/A |